Year: 2025
Type: article
Study design: Observational Study
Abstract: Background: COVID-19 is an infectious multisystem disease caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).Although abdominal manifestations have been observed in these patients, the relationship between hepatobiliary abnormalities and the progression of COVID-19 remains poorly defined.Imaging exams -such as Computed Tomography (CT) and magnetic resonance imaging (MRI) -have revealed hepatic and bile duct changes in these patients.However, few studies have demonstrated these findings through Ultrasound (US).Objective: To determine if abdominal US can be used as a prognostic marker in severe COVID-19 patients.Methods: A prospective, observational study in three specialized COVID-19 hospitals in Brazil from July 2020 to February 2021.We evaluated a convenience sample of inpatients, in both the intensive care unit (ICU) and nursery.Hepatobiliary US was performed by three radiologists who were blinded to all other patient-associated laboratory and clinical data.Information on sociodemographic and clinical variables was obtained from physical and electronic medical records.Fisher's exact test or chi-square test was performed according to data characteristics for each categorical variable.
Source: Journal of Surgery
Authors: Alice Abath Leite, Camila Silva Bezerra, Thaís Ramos da Costa, Felipe Alves Mourato Esdras Marques Lins, Emmanuelle Tenório Albuquerque Madruga Godoi, Lúcia Helena de Oliveira Cordeiro, Maria Cristina Falcão Raposo, Simone Cristina Soares Brandão
Language: English
Subfield: Infectious Diseases
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W4407591881